TTrialPathMatch Me to Trials
← Back to trials
RecruitingChronic Kidney Disease(CKD)Type 2 DMType 2 Diabetes Mellitus (T2DM)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Eligible age

18+ yrs

Accepts

All genders

Locations

6 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

Sponsor: Duke University

You may qualify if…

  • Adults with type 2 diabetes (T2D)
  • Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP).
  • Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR

You may not qualify if…

  • Chronic kidney disease (CKD) diagnosis

Where it's recruiting

Alabama

Birmingham

Florida

St. Petersburg

Michigan

Ann Arbor

Minnesota

Duluth

North Carolina

Durham · Houston

Texas

Temple

Source: ClinicalTrials.gov · NCT06906627 · last updated 2026-06-16